Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

extension   crawled date : 2022 - 09 - 28    save search

Atlantic Avenue Acquisition Corp Announces Intent to Adjourn Special Meeting to Approve Extension Proposal
Published: 2022-09-28 (Crawled : 23:00) - prnewswire.com
ASAQ | $10.03 0.0% twitter stocktwits trandingview |
Finance
| | O: -0.3% H: 0.25% C: 0.1%

acquisition meeting extension proposal
Lomiko announces the third round of analytical results from the infill and extension exploration drill program at La Loutre Graphite property, drilling wide high-grade intersections at 11.02% Cg over 120m at the northern end of EV Zone
Published: 2022-09-28 (Crawled : 15:00) - lomiko.com
LMRMF | $0.0104 1111.71% 1K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 0.77% H: 0.0% C: -0.38%
LTUM | $0.0347 33.16% 180K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: -3.14% H: 3.24% C: -3.45%
CRECF | $0.486 0.15% 11K twitter stocktwits trandingview |
Process Industries
| | O: -5.42% H: 8.37% C: 7.49%

extension program results
FDA Authorizes an Extension of the In-Use Period for UroGen Pharma’s JELMYTO® Admixture to 96 Hours Following Reconstitution
Published: 2022-09-28 (Crawled : 13:00) - biospace.com/
URGN | $14.27 -1.52% -1.54% 180K twitter stocktwits trandingview |
Health Technology
| | O: 1.99% H: 9.99% C: 5.48%

jelmyto fda extension
KLX Energy Services Announces Amendment and Extension of ABL Facility
Published: 2022-09-28 (Crawled : 13:00) - prnewswire.com
KLXE | News | $7.0 -4.5% -4.71% 250K twitter stocktwits trandingview |
Industrial Services
| | O: 2.8% H: 34.18% C: 26.73%

energy services extension
Elbit Systems Announces Extension of 2020 Shelf Prospectus In Israel
Published: 2022-09-28 (Crawled : 08:00) - prnewswire.com
ESLT | News | $197.35 -1.6% -1.63% 8.9K twitter stocktwits trandingview |
Electronic Technology
| | O: -0.73% H: 0.0% C: -0.41%

extension israel
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
Published: 2022-09-27 (Crawled : 00:00) - biospace.com/
TARS | $34.44 -1.32% -1.34% 330K twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 7.23% C: 3.51%

tp-03 treatment care extension eye trial study
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.